Abstract: Nasopharyngeal carcinoma is a common head and neck malignancy with distinct clinical management compared to other types of cancer. Precision risk stratification and tailored therapeutic ...

Create Your Own Cardboard Zoetrope: DIY Animation Machine Guide Discover how to build an amazing DIY animation machine using cardboard! In this tutorial, we'll guide you to craft a cardboard animation ...

To learn more about how drugs that work on the immune system are used to treat cancer, see Cancer Immunotherapy. To learn about some of the side effects listed here and how to manage them, see ...

eInstitute of Otorhinolaryngology, Clinical Research Center, Eye and ENT Hospital, Fudan University, Shanghai, China fDepartment of Otorhinolaryngology, Huazhong University of Science and Technology ...

The median progression-free survival per blinded independent review was 9.6 months in the penpulimab arm and 7.0 months in the placebo arm. Adding penpulimab to chemotherapy can improve ...

The US Food and Drug Administration (FDA) has approved penpulimab-kcqx (Akeso Biopharma) in combination with cisplatin or carboplatin and gemcitabine as first-line treatment for adults with certain ...

Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer, where the endemic subtype is strongly associated with Epstein-Barr virus (EBV) infection, whereas emerging data suggest that a subset ...

Deborah Wong, MD, PhD, discusses therapeutic options for patients with nasopharyngeal carcinoma. Deborah Wong, MD, PhD, associate clinical professor in the Department of Medicine, Division of ...

The NCCN Guidelines Version 1.2025 for Cancer of the Nasopharynx listed toripalimab plus chemotherapy as the standalone preferred regimen in the frontline treatment of patients with advanced ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Chemoradiotherapy has ...